Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glaab, W. E.
Right arrow Articles by Skopek, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glaab, W. E.
Right arrow Articles by Skopek, T. R.
[Cancer Research 60, 4921-4925, September 1, 2000]
© 2000 American Association for Cancer Research


Molecular Biology and Genetics

Specificity of Mutations Induced by the Food-associated Heterocyclic Amine 2-Amino-1-methyl-6-phenylimidazo-[4,5-b]-pyridine in Colon Cancer Cell Lines Defective in Mismatch Repair

Warren E. Glaab1, Kristy L. Kort and Thomas R. Skopek

Merck Research Laboratories, Department of Genetic and Cellular Toxicology WP45-320, West Point, Pennsylvania 19486

Recently, we have shown a hypermutable response to the food-associated heterocyclic amine 2-amino-1-methyl-6-phenylimidazo-[4,5-b]-pyridine (PhIP) in human cells defective in mismatch repair (MMR). These findings suggest that exogenous compounds such as PhIP may play an important role in the generation of tumors in MMR-defective individuals. The specificity of mutations induced by PhIP exposure at the endogenous HPRT locus was determined in cell lines defective in MMR to better understand the mutagenic effects of PhIP in MMR-defective individuals and to gain insight into the molecular mechanism of carcinogenesis induced by PhIP. Eighty-six induced HPRT mutants from two different cell lines were isolated and sequenced after exposure to 10 µM PhIP. Nineteen (22%) of these mutants contained G:C to T:A transversion mutations, consistent with the promutagenic adduct of PhIP at the C8 position of guanine miscoding with adenine. This level of PhIP-induced G:C to T:A transversions was ~4.5-fold higher than spontaneous G:C to T:A frequencies. Additionally, a hotspot for mutation was observed in a run of six guanines in HPRT exon 3, where a total of 23 (27%) of all PhIP-induced mutations occurred. These mutations consisted of transversions, transitions, and frameshift mutations. The increase in mutant frequency at this run of guanines corresponded to a 24-fold elevation above the spontaneous frequency in one cell line and a 3.3-fold increase in the other. These data suggest that PhIP may increase the risk of human carcinogenesis mediated by MMR by increasing mutations at runs of guanine residues. PhIP may thereby promote tumorigenesis by mutating growth-regulating genes that contain runs of guanines in their coding sequences, such as BAX, the insulin-like growth factor II receptor IGFIIR, and even the mismatch repair gene hMSH6.




This article has been cited by other articles:


Home page
Toxicol SciHome page
S. Creton, H. Zhu, and N. J. Gooderham
A Mechanistic Basis for the Role of Cycle Arrest in the Genetic Toxicology of the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
Toxicol. Sci., April 1, 2005; 84(2): 335 - 343.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A. Andreassen, R. Vikse, I.-L. Steffensen, J. E. Paulsen, and J. Alexander
Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele
Mutagenesis, July 1, 2001; 16(4): 309 - 315.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Bardelli, D. P. Cahill, G. Lederer, M. R. Speicher, K. W. Kinzler, B. Vogelstein, and C. Lengauer
Carcinogen-specific induction of genetic instability
PNAS, April 5, 2001; (2001) 81082898.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
N. Watanabe, E. Okochi, Y. Hirayama, Y. Shimada, K. Yanagihara, M. C. Yoshida, S. Takahashi, M. Mochizuki, T. Sugimura, M. Nagao, et al.
Single Nucleotide Instability without Microsatellite Instability in Rat Mammary Carcinomas
Cancer Res., March 1, 2001; 61(6): 2632 - 2640.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Bardelli, D. P. Cahill, G. Lederer, M. R. Speicher, K. W. Kinzler, B. Vogelstein, and C. Lengauer
From the Cover: Carcinogen-specific induction of genetic instability
PNAS, May 8, 2001; 98(10): 5770 - 5775.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.